Updated July 13, 2012
Raleigh firm seeking 'female Viagra' raises $20 million
Raleigh, N.C. —Nearly 60 individual investors flock to support Sprout Pharmaceuticals, which is working toward FDA approval for a compound developed to treat hypoactive sexual desire disorder. It's a form of female sexual dysfunction that essentially means low sexual desire.Copyright 2013 WRAL Tech Wire. All rights reserved.
Please log in to view WRALTechWire Insider content
Please Log In to add a comment.